clinical trial · NCT07480395
Real-World Data Collection of the GORE Devices When Used in the Treatment of Aortic Pathologies Which Requires the Incorporation of the Visceral Arteries.
W.L.Gore & Associates·—·not yet recruiting·n = 400
Complex Aortic AneurysmsThoracoabdominal AneurysmFenestrated Endovascular Aortic RepairEndovascular Aortic RepairAbdominal Aorta Aneurism
brief summary
The registry population consists of patients presenting with complex aortic pathologies amenable to endovascular aortic repair that requires the incorporation of bridging stents to maintain visceral artery perfusion
started
Dec 1, 2026
primary completion
Dec 1, 2031
completion
Dec 1, 2035
last updated
Mar 18, 2026
detailed description
Patients are eligible to participate in the registry if at least one BXB device is intended to be incorporated (first proximal, connected with aortic main body) to maintain visceral artery perfusion. There are no selection criteria (i.e., inclusion or exclusion criteria) based on main aortic body device used, and to allow better RWD representation of the patient population treated with different aortic component, a cap per main aortic body device has been set
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol